Claims
- 1. A composition comprising:
an aliquot of the herb Herba Epimedii; and an aliquot of at least three supplemental herbs selected from the group consisting of Fructus Rosae Laevigatae; Fructus Rubi; Fructus Psoralea; Radix Morindae Officinalis; Fructus Schisandrac Chinensis; Fructus Ligustri Lucidi; Semen Cuscutae; and Radix Astragali.
- 2. The composition of claim 1, wherein the aliquot of the herb Herba Epimedii and the aliquot of the at least three supplemental herbs comprises an extract.
- 3. The composition of claim 2, wherein the extract of Herba Epimedii is about 25% to about 65% by weight of the composition.
- 4. The composition of claim 2, wherein the supplemental herb comprises an extract of Radix Morindae Officinalis in an amount of about 1% to about 10% by weight of the composition.
- 5. The composition of claim 2, wherein the supplemental herb comprises an extract of Fructus Rosae Laevigatae about 1% to about 20% by weight of the composition.
- 6. The composition of claim 2, wherein the supplemental herb comprises an extract of Fructus Rubi is about 1% to about 20% by weight of the composition.
- 7. The composition of claim 2, wherein the supplemental herb comprises an extract of Fructus Schisandrac Chinensis is about 1% to about 10% by weight of the composition.
- 8. The composition of claim 2, wherein the supplemental herb comprises an extract of Fructus Ligustri Lucidi is about 1% to about 10% by weight of the composition.
- 9. The composition of claim 2, wherein the supplemental herb comprises an extract of Semen Cuscutae is about 1% to about 10% by weight of the composition.
- 10. The composition of claim 2, wherein the supplemental herb comprises an extract of Fructus Psoralea is about 1% to about 20% by weight of the composition.
- 11. The composition of claim 2, wherein the supplemental herb comprises an extract of Radix Astragali is about 1% to about 10% by weight of the composition.
- 12. A method comprising contacting a prostate cell with the composition of claim 1.
- 13. A method comprising:
identifying a subject with a prostate disorder; and establishing a regimen for administering the composition of claim 1.
- 14. The method of claim 13, wherein the disorder is prostate cancer.
- 15. The method of claim 13, wherein the disorder is erectile dysfunction.
- 16. The method of claim 14, wherein the prostate disorder comprises elevated PSA levels in serum.
- 17. A method comprising:
identifying a subject with a kidney disorder; and establishing a regimen for administering the composition of claim 1.
- 18. The method of claim 17, wherein the kidney disorder is polyuria.
- 19. The method of claim 17, wherein the kidney-disorder is incontinence.
- 20. The method of claim 19, wherein said incontinence is nocturnal incontinence.
- 21. The method of claim 16, wherein the kidney-disorder is proteinuria.
- 22. A composition comprising:
icariin; ursolic acid; ellagic acid; psoralen; deoxyschizandrin; oleanolic acid; quercetin; aslvagaloside; and an extract of the herb Radix Morindae Officinalis.
- 23. The composition of claim 22, wherein the concentration of icariin is about 1.6% of the composition.
- 24. The composition of claim 22, wherein the concentration of psoralen is about 0.3% of the composition.
- 25. The composition of claim 22, wherein the concentration of deoxyschizandrin is about 0.06% of the composition.
- 26. The composition of claim 22, wherein the concentration of oleanolic acid is about 0.013% of the composition.
- 27. A method comprising contacting a prostate cell with the composition of claim 22.
- 28. A method comprising:
identifying a subject with a prostate disorder; and establishing a regimen for administering the composition of claim 22.
- 29. The method of claim 28, wherein the disorder is prostate cancer.
- 30. The method of claim 28, wherein the disorder is erectile dysfunction.
- 31. The method of claim 28, wherein the prostate disorder comprises elevated PSA levels in serum.
- 32. A method comprising:
identifying a subject with a kidney disorder; and establishing a regimen for administering the composition of claim 22.
- 33. The method of claim 32, wherein the kidney disorder is polyuria
- 34. The method of claim 32, wherein the kidney-disorder is incontinence.
- 35. The method of claim 34, wherein said incontinence is nocturnal incontinence.
- 36. The method of claim 32, wherein the kidney-disorder is proteinuria.
- 37. A method comprising administering the composition of claim 22 in an amount effective to improve sexual function.
- 38. A method comprising administering the composition of claim 22 according to a regimen effective to maintain or establish proper function of kidney-related organs.
CROSS-REFERENCE TO RELATED APPLICATION
[0001] This application claims the benefit of the earlier filing date of co-pending provisional application Serial No. 60/306,112, filed Jul. 17, 2001, by Wen Hsein Chou, titled “Compositions and Methods for the Treatment of Prostate Disorders with an Herbal Preparation,” and incorporated herein by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60306112 |
Jul 2001 |
US |